5 studies found for:    19325447 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine
Condition: Pneumococcal Infections
Interventions: Biological: Pneumococcal conjugate vaccine GSK1024850A;   Biological: Prevenar;   Biological: Tritanrix-HepB;   Biological: Hiberix;   Biological: Polio Sabin.;   Biological: Poliorix.
2 Completed Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
Condition: Prophylaxis Pneumococcal Vaccine
Intervention: Biological: Pneumococcal (vaccine)
3 Completed
Has Results
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
Conditions: Pneumococcal Disease.;   Meningococcal Disease.;   Streptococcus Pneumoniae Vaccines
Interventions: Biological: Pneumococcal conjugate vaccine GSK1024850A;   Biological: Prevenar;   Biological: Infanrix hexa;   Biological: Infanrix IPV Hib;   Biological: Infanrix penta;   Biological: Infanrix IPV;   Biological: Meningitec;   Biological: NeisVac-C;   Biological: Menitorix
4 Completed A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study
Condition: Pneumococcal Disease
Intervention: Biological: Pneumococcal (vaccine)
5 Completed Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
Condition: Pneumococcal Disease
Intervention: Biological: 10 valent pneumococcal conjugate (vaccine)

Indicates status has not been verified in more than two years